PT  - JOURNAL ARTICLE
AU  - Köksaldi, İlkay Çisil
AU  - Ahan, Recep Erdem
AU  - Köse, Sila
AU  - Haciosmanoğlu, Nedim
AU  - Şahin Kehribar, Ebru
AU  - Güngen, Murat Alp
AU  - Özkul, Aykut
AU  - Özgür Şafak Şeker, Urartu
TI  - SARS-CoV-2 detection with de novo designed synthetic riboregulators
AID  - 10.1101/2020.07.28.20164004
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.28.20164004
4099  - http://medrxiv.org/content/early/2020/07/30/2020.07.28.20164004.short
4100  - http://medrxiv.org/content/early/2020/07/30/2020.07.28.20164004.full
AB  - Sars-CoV-2 is a human pathogen and is the main cause of COVID-19 disease. COVID-19 is announced as a global pandemic by World Health Organization. COVID-19 is characterized by severe conditions and early diagnosis can make dramatic changes both for personal and public health. In order to increase the reach for low cost equipment which requires a very limited technical knowledge can be beneficial to diagnose the viral infection. Such diagnostic capabilities can have a very critical role to control the transmission of the disease. Here we are reporting a state-of-the-art diagnostic tool developed by using an in vitro synthetic biology approach by employing engineered de novo riboregulators. Our design coupled with a home-made point-of-care device setting can detect and report presence of Sars-CoV-2 specific genes. The presence of Sars-CoV-2 related genes triggers translation of sfGFP mRNAs, resulting in green fluorescence output. The approach proposed here has the potential of being a game changer in Sars-COV-2 diagnostics by providing an easy-to-run, low-cost-demanding diagnostic capability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe are supported through TUBITAK-COVID Platform Research GrantAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We do not have an animal or human subject, or samples from any patientsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe do not have any patient data set.